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Abstract
Purpose—To understand the factors that facilitate career success for career development 
awardees in clinical and translational science and to reconceptualize understanding of career 
success for this population.
Method—In 2013–2014, the authors conducted semi-structured interviews with former NIH KL2 
or K12 scholars from nine Clinical and Translational Science Award-funded institutions. 
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Participants either had or had not secured independent funding at least two years after the end of 
their last K award. Questions covered the factors that facilitate or hinder junior investigators’ 
transition to independent funding. Interviews were recorded and transcribed and the transcripts 
analyzed thematically.
Results—Forty individuals participated, with equal representation by men and women and by 
independently and not independently funded investigators. Personal factors that facilitated success 
included: networks, persistence and resilience, initiative, autonomy, and personal and professional 
balance. Organizational factors included: appropriate mentorship, protected research time, and 
institutional resources and support.
Even independently funded participants described challenges regarding career direction. Five 
participants without independent funding modeled a broad spectrum of successful career paths, 
having assumed leadership positions not reliant on grant funding. Alternative definitions of career 
success included: improving public health, enjoying work, seeing mentees succeed, and receiving 
external acknowledgement of successes.
Conclusions—Awareness of the factors that facilitate or hinder career success can help junior 
faculty, mentors, and institutional leaders support career development in clinical and translational 
science. New definitions of career success are needed, as are career paths for faculty who want to 
engage in research in roles other than principal investigator.
The “leaky pipeline” in academic biomedical research has been well documented.1–3 The 
National Institutes of Health (NIH) has taken steps to address the high rates of investigator 
attrition in academia, including creating special policies and funding opportunities for early-
career investigators. Career development awards (called K awards when funded by NIH) 
provide junior faculty with protected time to conduct research and engage in training under 
the guidance of a mentor, with the purpose of providing them with the training and data 
acquisition necessary to secure independent funding.4 In taking these steps, NIH aimed to 
help investigators navigate the portion of their career path where many change trajectories—
the transition from a mentored trainee to an independent principal investigator (PI). 
Nevertheless, the rates of transition from a K award to independent funding are low. Fewer 
than 25% of K awardees receive an independent research grant (R01) within five years of 
receiving a K award,5 and only 10%–11% obtain a second R01.6
K awardees need substantial support to become competitive as independent investigators in 
today’s highly competitive funding environment. Some institutions with a Clinical and 
Translational Science Award (CTSA) created “K to R” programs that facilitate the transition 
to independent funding for their K awardees, but little research has evaluated the 
effectiveness of these programs, which are heterogeneous in design. Studies of specific 
programs, however, have found that some organizational or personal factors do contribute to 
this transition.7 These organizational or program factors include: the augmentation of 
research funds by private sources (e.g., foundations),8 mentoring9,10 (particularly when 
centrally overseen11), protected time for research training,11 grant writing training and 
support,10 time management training,10 and access to statisticians and other experts.10 
Personal factors include: experience publishing peer-reviewed papers early in one’s career12 
and early submission of extramural grants.11
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As the moniker “K to R” suggests, the purpose of these programs is to provide early-career 
faculty with the additional support they need to secure independent funding for their 
research. This transition has traditionally been an important metric by which investigators’ 
career success has been judged. In recent years, however, team science has become more 
important for advancing new knowledge13 and federal grant funding has declined.14 These 
changes suggest the need to reconsider the traditional concept of “success” for clinical and 
translational investigators, to reflect both the manner in which research is often conducted 
and the funding climate. They also suggest the need for a new understanding of the 
definition of a successful career path and of the metrics to evaluate success.15
Rubio and colleagues16 suggested a comprehensive model of career success for physician-
scientists that has yet to be tested empirically. It details the personal and organizational 
factors that contribute to various types of success, which may be extrinsic or intrinsic. 
Extrinsic success is readily visible to others, such as financial success (both personal 
finances and grant funding), publications, leadership positions, and promotions in academic 
rank. Intrinsic success is more subjective and personal, mainly centering on career and life 
satisfaction, such as whether individuals feel they have achieved their self-defined career 
goal(s).
In 2012, the CTSA Education and Career Development Key Function Committee formed a 
work group to examine the factors that facilitate or hinder K awardees’ transition from a 
mentored career development award to independent funding. A subset of the members of 
this group conducted a qualitative study, based on the Rubio model of career success, to 
examine the personal and organizational factors that support or hinder this transition from an 
institutional mentored career development award (KL2 or K12) to independent funding (R01 
or R01-equivalent funding). In addition, this work group wished to gain insight into K 
awardees’ definitions of career success.
Here, we report the findings of this study, including the personal and organizational factors 
that participants identified as facilitating a successful transition to independent funding, their 
perceptions of career success, and some of the career challenges they experienced.
Method
We designed a semi-structured interview guide, which included questions that covered the 
main elements in the Rubio model of physician-scientist career success,16 such as 
psychosocial factors, education, personality (research motivation, passions, leadership, 
professionalism), career support, professional responsibilities, and success factors. We also 
included questions about career plans, concerns, regrets, and factors that helped or hindered 
career progress. In total, there were 20 questions (see Supplemental Digital Appendix 1 at 
[LWW INSERT URL]). We piloted the questions with four KL2 alumni volunteers from a 
large Midwestern CTSA-funded institution, refining the questions as appropriate after the 
pilot.
Since organizational factors could play a role in career success,16 we wanted participants to 
come from a number of institutions across the United States. We chose to include alumni 
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from KL2 programs and the KL2 program precursor, the Roadmap K12 (hereafter referred 
to collectively as “KL2”), because we assumed that institutions with CTSAs would provide 
substantial centralized support for their KL2 scholars. This purposive sampling17 allowed us 
to capture investigators who either had or had not transitioned to independent funding, 
despite supportive institutional structures to help them succeed, deepening our 
understanding of the factors that facilitate or hinder career progression. We reviewed 
institutional websites to determine which institutions with CTSAs awarded in 2006 and 
2007 had the most KL2 alumni. We limited the data to these two years to ensure that a 
reasonable time had passed from the start of participants’ K awards to their possible 
transition to independent funding. We selected 10 institutions to achieve geographic 
representation, as well as a balance of public and private institutions. The University of 
Pittsburgh institutional review board deemed this study exempt. All participating institutions 
either obtained approval from their respective institutional review boards or did not need it 
because data collection and storage took place at the University of Pittsburgh.
We asked KL2 directors and administrators to identify faculty who had been supported by 
their KL2 mechanism and who met either of the following criteria: (1) had secured an R01 
or grant of an equivalent size as PI or had scored in the top quartile for an R01 application; 
or (2) had not secured an R01 or equivalent grant as PI and for whom two years or more had 
passed since the end of their last career development award (including an individual K 
award they may have been awarded subsequent to the KL2). Administrators asked eligible 
alumni to contact a member of the study team if they were willing to participate. We aimed 
to interview 40 alumni in total—20 independently funded (IF) and 20 not independently 
funded (NIF) individuals. If we did not reach theoretical saturation after these interviews, we 
planned to continue the interviews until no new themes emerged.
One member of the study team (G.F.W.B.R.) conducted all the interviews between July 
2013 and April 2014. Interviews were conducted using either video-conferencing software 
(n = 22; 55.0%) or in person meetings (n = 7; 17.5%), with the remaining interviews 
conducted over the telephone (n = 11; 27.5%). Participants verbally consented to participate 
and to be recorded at the beginning of each interview. Interviews were recorded and 
transcribed. All participants were assigned pseudonyms, which were employed for 
transcription, analysis, and reporting here. Transcripts were checked and coded by one 
member of the study team (G.F.W.B.R.), while a second member of the team (L.S.S.) coded 
25% of the transcripts to ensure that the team explored a range of competing possible 
interpretations.18 Any disrecepencies were resolved by the members of the study team who 
reached conceptual agreement on the themes embedded in the data. We used QSR 
International’s NVivo software, versions 8 and 10 (Doncaster, Australia).
We began coding with deductively derived codes, based on the Rubio model,16 adding to 
these codes inductively as themes emerged. We used memos to develop data interpretation 
and consulted the relevant literature to help us refine our understanding of inductively 
emerging theories. Coding and analysis began while the interview process was in progress, 
allowing the interviewer to solicit further information from subsequent participants about 
emerging themes, when relevant. We engaged in member checks19 by sending participants 
drafts of this paper and asking them to comment on whether they felt that sections 
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particularly pertaining to their experiences were appropriately represented; we also offered 
them an opportunity to request or suggest changes to our interpretation, analysis, and 
reporting of their particular experiences or quotations.
Results
Participants
Nine institutions agreed to participate (see Table 1). The tenth was conducting its own 
interviews to evaluate its KL2 program at that time and did not want to burden KL2 alumni. 
Forty eligible KL2 alumni volunteered to participate from the nine institutions, with equal 
representation by men and women. Twenty (50.0%; 10 men, 10 women) had successfully 
transitioned to independent funding. Participants were predominantly non-Hispanic and 
white (see Table 2) and all worked at academic institutions. Sixteen (40.0%) were associate 
professors, while the remainder were assistant professors (see Table 2). Participants 
represented a wide range of disciplines, including medical specialties, surgical sub-
specialties, psychology and psychiatry, social work, and non-medical health science and 
clinical fields.
Personal factors
The personal factors identified by participants as important for a successful transition from 
mentored research to independent funding were: (1) networks, (2) persistence and resilience, 
(3) initiative, (4) autonomy, and (5) personal and professional balance. Participants noted 
that the absence of one of these factors had a detrimental impact on their careers.
Networks—Many participants noted that relationships are a vital part of research and thus 
they prioritized the intentional development of interpersonal skills:
There’s a very human part to what we do. It’s not just science…You need to be 
able to network, you need to be able to talk to people, you need to work with them. 
I increasingly feel that these soft factors are just as important, if not more 
important, than your technical ability. (Charles, IF)
Participants described how having the right research team, both locally and nationally, can 
lead to career enjoyment and productivity, and many even said that developing a network 
was one of the most enjoyable aspects of conducting research.
IF participants revealed that they had been proactive about building their research networks 
locally, nationally, and internationally:
The other part that I think is important and that has to be done very strategically is 
networking with people at national meetings, and being willing to go to these 
meetings and really investing in that time, saying, “I want to come out of this 
meeting with four or five people that know me, that know what I work on, that can 
associate my name with a field of study. And if I can do that, they are now folks 
that I can link arms with.” (William, IF)
Being part of a group of faculty with related but distinct research interests was instrumental 
to some participants because everyone in the group collaborated. Inclusion in such a group 
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offered intellectual, emotional, and financial support to all involved. A good network was 
particularly important for NIF participants who were engaged in research in a collaborative 
role. Strong local and national connections enabled these participants to continue their 
research endeavors. Feeling connected to one’s colleagues also helped to fuel resilience and 
persistence, in addition to unveiling new research opportunities and making work more 
enjoyable. Hearing from IF colleagues or others who had navigated similar challenges 
helped provide participants with the impetus to continue through what they perceived as a 
struggle.
NIF participants frequently described how a poor or limited network hampered their 
research progress. Without a network, research can become isolating and unproductive: 
“People aren’t successful on their own” (Tabitha, NIF) and “Part of the struggle…is that I’m 
the only person doing this here” (Rebecca, NIF). Some participants had no local colleagues 
doing similar research and noted the negative effect this had on their productivity.
Persistence and resilience—Participants, both IF and NIF, displayed strong resilience 
to the multiple challenges of conducting research and dogged persistence to continue in their 
research endeavors. Some participants recognized resilience as a personality trait, but most 
saw it as a learned skill, modeled for them by parents, colleagues, and mentors:
I had to learn to have tough skin and be persistent. I mean, everybody has to learn 
that, but we see so many people who just crumble at the critiques at some point. 
And I have so many rejections. The conventional wisdom would be that I should be 
out by now, that I should have been out a while ago. (Olivia, IF)
To maintain resilience and persist in their careers, participants recognized incremental 
rewards other than the final publication or notice of grant award. These rewards could be 
small steps along the path to achieving their main goal or the realization of improved 
research results after having one’s initial beliefs or directions proved incorrect or 
suboptimal.
The participants who spoke most clearly about resilience and persistence were all IF. While 
all participants articulated the importance of these attributes and felt they possessed them, a 
few articulated a lack of motivation in their career that could erode persistence and 
resilience. Most framed the need for persistence and resilience in a positive light, while still 
finding it an unfortunate reality of conducting biomedical research. A minority, however, 
were more critical of this need. Robert (IF), who was well funded, expressed how the 
pressure to persevere led to feelings of burnout, especially since the rewards of working hard 
often led to being assigned even more “research-related responsibilities and service-related 
tasks,” rather than being able to pursue his own, more intrinsically rewarding, research. He 
also questioned the work’s effect on his home life and whether the reward was worth the 
effort of persisting:
[Research requires] a tremendous amount of self-sacrifice. It’s a blurring of 
personal and professional lines that is in the order of completely unreasonable and 
not sustainable to achieve the goals that are asked of us…You miss out on life a lot. 
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So you give up a lot to do this. And then you start reflecting, “What the hell am I 
doing?”
Initiative—Many IF participants had taken the initiative to control and drive their career. 
They were intentional and “somewhat assertive” (Diana, IF) in reaching out for help from 
colleagues and experts with whom they had no prior relationship. In general, successful 
participants felt that the onus to succeed rested with them and that they needed to engineer 
their success. For example, Adam (IF) noted: “You just need to be attentive for 
opportunities and seize them when they show up.”
Some participants had taken specific, and sometimes unconventional, measures to ensure 
their success. Caroline (IF), who had successfully established a population that was willing, 
even eager, to participate in her clinical research, had spent a substantial amount of time 
talking to community groups about her work and its health implications. Despite the large 
amount of time involved, she was driven to do it because of an uncompromising desire to 
succeed: “I knew that this is what I wanted to do, and I knew to accomplish this I was going 
to have to do something different.”
Autonomy—Feeling autonomous in multiple realms was important for career success and 
satisfaction. Autonomy enabled participants to take ownership of their work, choose what 
they worked on, and decline to participate in projects that would not benefit their career. 
Autonomy also allowed participants to organize their work schedule and environment to 
best meet their needs and enhance their productivity.
Participants viewed a faculty position with research responsibilities as inherently 
autonomous: “I think the thing that still motivates [me] is the fact that I can study new 
things, the intellectual freedom that is associated with this type of career” (Simon, IF). Some 
participants had been advised by colleagues and mentors to decline projects or invitations 
for specific types of work and service. Doing so allowed them to control the work they could 
perform well: “I say yes to projects that are thematically related to my interests. Every 
project I work on, including training and clinical work, is related to [my field]. That makes it 
feel more manageable because I’m not scattered. I don’t work on other things” (Nicholas, 
IF).
Working from home afforded participants quiet time to think and write without the 
distractions of the institutional environment. Quinn (IF) described exerting her autonomy in 
this regard: “A couple of years ago, I started working from home a lot more, and that has 
helped tremendously. It doesn’t always work, but I try to…[maintain a] writing day.” In 
addition, working from home allowed parents to be present for their children without 
jeopardizing their productivity:
The wonderful thing about research is that it’s a bit flexible. And so it is really 
good for when you have little kids because if you need to miss something in the 
morning, you can make it up at night. (Georgia, IF)
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Clinicians who enjoyed predictable service schedules could limit their clinical service to 
periods when their research demanded less of their time so they could focus on their patients 
without feeling a professional imbalance.
A lack of autonomy appeared to be the primary hindrance to securing independent funding 
for some NIF participants. Victoria (NIF), a methodologist, had limited autonomy because 
she was in more of a support role and because her husband’s career affected some of her 
professional decisions. Polly (NIF) and David (NIF) lacked the autonomy to organize 
sufficient time for research since they both had limited funding and considerable clinical 
demands. David was unhappy that he was not afforded any “time to think” during the work 
day. For Polly, the lack of autonomy manifested in fewer choices about what she worked on; 
being a co-investigator made it more difficult to maintain her own research focus.
Many participants agreed that the level of autonomy granted to an investigator must be 
appropriate to her or his career stage and abilities. Jack (IF) cautioned:
It’s a balance between guidance and autonomy when people are junior…and it’s a 
difficult balance to titrate. I would say it has worked out well for me, but 
[autonomy] hasn’t been a universal panacea for every career for every junior 
person.
Xander (NIF) had experienced an unusual amount of autonomy while he was a junior 
faculty member, having few senior investigators to guide him. While he viewed the freedom 
to engage in professional exploration positively, he also partially attributed his lack of 
success to it. Lacking direction and mentorship early on meant that he had no formal 
socialization into academic norms, which hindered his progress.
Personal and professional balance—Participants had varying views about balancing 
their personal life and professional work, regardless of their personal obligations (e.g., 
children and eldercare). A majority (n = 25; 62.5%) felt that they lacked, or struggled to 
find, work-life balance. Some participants adopted one or more approaches to viewing and 
achieving this balance, having seen these strategies employed by their colleagues or 
mentors. Doing so helped them feel content with how they divided their time between 
personal and professional activities. One such approach was to seek longer-term balance, 
dedicating appropriate amounts of time to their different roles over an extended period rather 
than judging balance on a daily basis:
There’s some subconscious assessment on a daily/weekly/monthly basis: do I think 
that I’ve met the quota that I wanted to meet for [hobby], or doing research, or 
spending time with my kids? I was just at a meeting and the two weeks before that I 
had been on clinical service, so the bowl for my children was a little empty. So the 
kids and I are going camping this weekend. That will fill up that bowl, and I’ll say, 
“Well, I probably need to focus on the research.” It’s this constant balance of as the 
water evaporates down, fill it back up like that. (Greg, IF)
A second approach was to reject the expectation of work-life balance and accept that 
creating any balance, at times, would be extremely challenging:
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The quest for balance is…both a moot and futile quest, because there is no perfect 
balance point that one achieves and maintains. It’s an ongoing process. When you 
recognize that [it is] a pendulum swinging, you are constantly thinking about what 
the most important pieces coming in. “If I do this then what? And what things are 
most important right now, in the short-term and in the long-term?”…If you think 
about that, you know that it’s a constant juggle, I think it helps to make one not feel 
overwhelmed. (Tabitha, NIF)
Organizational factors
Participants identified three organizational factors that facilitated the transition to 
independent funding: (1) mentors, particularly those who were generous with their time, 
advice, networks, and resources, and who role modeled the kind of career the participant 
wished to pursue; (2) protected time for research; and (3) institutional resources and support, 
such as a strong community of investigators, good research facilities, a supportive 
infrastructure for research, ample patient populations, and encouragement to delegate.
Mentors—Both IF and NIF participants identified mentorship as a critical factor in 
participants’ careers. Of the 40 participants, 36 (90.0%) mentioned mentorship or their 
mentors when asked who or what had been instrumental to their careers. However, the 
nature and definition of mentorship varied. Belinda (IF) was one of the four participants who 
did not mention mentorship. While most participants identified one or two mentors at 
different points in their career, Belinda rejected the idea of a single mentor providing all-
encompassing support. Instead, she described how clinical and translational investigators 
need five different types of mentors: (1) a scientific, or content, mentor who provides 
discipline-specific training and scientific guidance; (2) a career mentor who provides advice 
regarding the mentee’s career strategy and choices; (3) what she termed a “vent mentor,” a 
confidante who listens to the mentee’s professional troubles and provides an emotional 
outlet while maintaining confidentiality; (4) an impartial politically removed mentor, best 
fulfilled by a senior faculty member from a different department within the mentee’s 
institution; and (5) a peer mentor role model, who is someone the mentee aspires to be like 
but with whom he or she is not professionally connected. This peer mentor role model does 
not provide active mentorship, and may not even know that he or she fulfills this role. 
However, his or her actions serve as a guide, when appropriate. Other participants also 
described having multiple types of mentors.
Participants stated that the most helpful mentors established a trusting relationship and met 
specific needs, such as giving advice, providing resources, making their network of relevant 
investigators accessible, role modeling a successful career, and being generous with their 
time, particularly during the early stages of research development or just before a grant 
submission. Helpful advice from a mentor was not limited to scientific guidance or career 
strategy. It encompassed navigating institutional and local politics, finding an optimal 
balance between the demands of one’s personal life and work, securing the support of others 
when needed, and many other personal and professional issues. Several participants 
commented that seeking advice on the same issue from multiple mentors in different 
departments or disciplines was helpful as it provided divergent perspectives. Assimilating 
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these perspectives and contextualizing them to one’s circumstances allowed participants to 
reach what they considered optimal solutions.
Mentors provided different types of resources. For many participants, mentors provided vital 
financial resources for early research projects: “In residency, [my mentor] paid for my 
research. He gave me a lab bench, and he has been extraordinarily supportive since then” 
(Jack, IF). Some mentors guided participants to funding sources other than the highly 
competitive NIH. For other participants, access to particular technologies and/or study 
subject populations was a direct benefit of mentoring relationships:
[My mentors helped me] practically, by giving me access to subjects. The first 
studies that I did on the KL2 were things that we appended to the batteries being 
administered to people already coming through…So having people who had more 
resources than I did who let me benefit from them, that was very helpful. 
(Lawrence, IF)
Just as participants valued building their own networks, they appreciated access to their 
mentors’ networks and guidance regarding how best to use this social capital to advance 
their careers:
Good mentors are very generous with their own connections. Good mentors say, “I 
know so-and-so and they have this expertise. You should go talk to them,” and they 
help facilitate those connections. So throughout my career I have been fortunate to 
have those people who really helped advocate for me. (Helen, IF)
Mentors, as leaders in their fields, frequently are asked to participate in discipline-specific 
societies, meetings, study sections, or other opportunities. Often, mentors put forward their 
mentees for these opportunities instead of taking them for themselves, thereby propelling 
their mentees into their networks.
In addition, many mentors role modeled clinical and translational research careers. Given 
the different ways that faculty focus their research, service, teaching, and clinical care 
efforts, participants appreciated examples of successful careers and practical demonstrations 
of the impact career choices can have on one’s professional and personal lives:
One way [mentors help me] is modeling, seeing people who are managing their 
careers in ways I would like to emulate. That means scientifically and 
intellectually, but also in terms of work-life balance and in terms of research/
clinical/educational/administrative balance…I enjoy having a bunch of different 
people, none of whom are doing exactly what I want to do or is exactly what I want 
to be, but all provide pieces of it. (Jack, IF)
Participants also benefitted from observing specific professionally relevant skills that are 
less frequently taught in a formal setting, such as collaboration techniques and team work, 
acceptance of criticism, project management, and strategies to balance diverse work and 
personal demands.
One third of NIF participants credited their lack of a transition to independent funding partly 
to difficulties with their mentors; four experienced particular barriers, while the others had 
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mentors who simply were not as helpful as they might have been. Melanie (NIF) 
experienced a punitive relationship with her mentor, who was also her direct supervisor. In 
addition to unreasonable expectations when a family member was ill, he removed her from 
publications and grants to which she had measurably contributed and isolated her socially 
within the department. Elaine’s (NIF) mentor had a “challenging personality,” but she was 
the only local mentor in Elaine’s field. Ultimately, Elaine said, “She was not at all interested 
in my research. She was more interested in my work in her lab, which didn’t cost her 
anything.” As a result, Elaine struggled to make progress. When she sought access to her 
mentor’s network and additional support, she was told, “This is hard work; you’ll have to do 
it yourself.” Julia (NIF) was working with a mentor productively for a year when he 
abruptly stopped responding to her about a manuscript from their project. The mentor 
retained the data from the project and was unwilling to share them with her, despite the best 
efforts of senior colleagues to intervene. This caused a notable delay in her progress because 
she had to establish a new research project and build a new mentoring team. Yvonne’s (NIF) 
primary mentor left the institution during Yvonne’s first year on faculty, and she and her 
replacement mentor were not a good fit. Yvonne eventually found a mentor with whom she 
worked well but whose content area was not the best match for her work, which produced 
some challenges in terms of content advice and networking.
Protected time for research—Many participants noted that the 75% protected time for 
research and research training provided by their KL2 award was critical to developing their 
research: “Having protected time to learn and write [has been instrumental to my career]…
Every task that I have spent time on has been related to moving my research forward” 
(Diana, IF). It allowed them to be productive and establish themselves in their fields, 
develop relationships with mentors and colleagues, and plan a strategic research agenda. 
However, KL2 awards vary in length by institution. Participants in two-year programs 
commented that, while the protected time was helpful, two years were insufficient to allow 
for substantive development of their research, making it difficult to submit an R01 
application in that timeframe.
A few participants encountered problems receiving or maintaining the 75% protected time 
for research funded by their K award. This hindered their ability to develop their research 
project sufficiently to secure independent funding. Tabitha (NIF) was assigned clinical 
duties that amounted to 65% effort while she was on a KL2 award, and she was unable to 
secure political support to remedy this situation. Rebecca’s (NIF) K award protected 75% of 
her time for two years, with the understanding that her department would provide a third 
year of financial support at this level. However, the department required her to be a co-
investigator on others’ grants in the third year to support her time, obligating her to 
contribute to their research rather than pursue her own.
Institutional resources and support—Participants mentioned four institutional 
resources that they viewed as important to their career success: (1) a strong community of 
investigators, (2) good research facilities with logistical support, (3) ample study subjects in 
relevant patient populations, and (4) the ability to delegate. Participants appreciated all these 
institutional resources more or less equally.
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A strong community of investigators allowed participants to obtain feedback on their ideas 
from experts, and importantly, provided them with multiple collaborative opportunities, 
which expanded their research network, broadened their areas of expertise, provided 
different research experiences, increased their number of publications, and provided salary 
support as a co-investigator. Collaborations also accelerated participants’ research, as many 
of the necessary infrastructure pieces and resources specific to their field were already in 
place. In addition to building and fostering networks in particular fields, participants 
especially appreciated institutions that intentionally built and propagated a highly 
collaborative culture.
Senior faculty and leaders who understood the demands of research were seen as highly 
supportive of research careers and instrumental in fostering communities of related 
investigators. These senior individuals provided professional emotional support and 
guidance and, frequently, tangible resources to help junior faculty surmount challenges. 
Joe’s (NIF) new division chief was a clinical investigator who brought to the fore many 
extant resources, such as help with institutional review board protocols and collaboration 
facilitation, of which Joe, as a newly hired faculty member, had been previously unaware.
Both IF and NIF participants appreciated access to specific research infrastructure, physical 
facilities, and logistical support. This included educational curricula in clinical and 
translational research; clinical and translational science degree programs; pilot funding; 
statistical support; help with proposal and manuscript development and editing; mock study 
sections; leadership training and other professional development opportunities; help with 
preparing institutional review board protocols; administrative support; professional grants 
management support; and access to a clinical and translational research center or other units 
available for research participant visits. Many of these services were available either through 
KL2 programs or a CTSA. Others, however, existed because of the vision and support of a 
division or department chair who provided research infrastructure and support for his or her 
faculty.
Access to patient populations relevant to their specific research agendas provided faculty 
with a steady supply of study participants with specific diseases or attributes. Institutions 
with a large, well-known clinical expertise in a particular area tend to attract patients with 
illnesses or other health problems related to that field. They also often have other studies in 
place, including clinical trials, to which junior faculty may be able to add a small study or 
from which they may be able to obtain secondary data to analyze. William (IF) illustrated 
this characteristic of his institution:
[Our institution] has a pretty sizable contract from NIH, and it allows us to do a lot 
of different trials. Our portfolio is so broad that we can do a lot of side projects as 
well. So I get to do [one] study and then say, “Well I could do those same 
techniques on [another] study.”
These resources provide an efficient way to build a publication record, establish oneself in 
the field, and develop new research ideas.
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The final manner in which institutions supported participants was by providing staff to 
whom tasks could be delegated and/or helping faculty learn to delegate. Some participants 
had a staff member who “manages everything” (Greg, IF) in their research group. Others 
had excellent access to research or administrative professionals:
All of those folks do the day-to-day and without them, I don’t know what we would 
do, because they are instrumental. And then I have an amazing laboratory manager 
and a couple of junior faculty members whom I am mentoring that run the 
laboratory. So [I feel like] a conductor making sure that all of the positioned 
players are just knocking it out. I can help where I need to, but some things are on 
autopilot. (William, IF)
Delegation was not easy for some participants, however. They needed help to work out to 
whom and how to delegate specific work. Some participants were just learning to delegate 
or it was something to which they aspired: “I could be better at having people with other 
skillsets do things for me. Sometimes I am uncomfortable asking other people to do that 
even though it may be part of their job description” (Edward, NIF). Being surrounded by a 
competent team to which they could delegate, often provided by the institution, greatly 
facilitated participants’ comfort in assigning tasks.
A lack of institutional resources presented obstacles for a few participants. Felix (NIF) and 
Edward (NIF) moved institutions and were confronted by the relative lack of research 
infrastructure to support their work at their new institutions. Paul’s (NIF) workplace was not 
near most of his institution’s research infrastructure. Although his dean was very supportive 
of his research efforts, he had a limited number of senior colleagues in his field nearby.
Most NIF participants lacked one or more of the beneficial personal or organizational factors 
described above. Some could not identify a specific barrier but felt that they needed more 
time to secure their funding, which could be interpreted as a lack of initiative, a lack of 
protected time, a lack of effective mentoring, or the absence of a comprehensive panoply of 
helpful factors. A minority of NIF participants, however, attributed their current lack of 
independent funding to an unusual series of personal or family issues. These unforeseeable 
and unavoidable circumstances demanded their time and energy, and prevented them from 
focusing on their work for a while, or necessitated relocation, which was disruptive to their 
careers. In these cases, NIF participants felt that, with additional time and support, they 
would be able to secure independent funding.
Supplemental Digital Tables 1–2, available at [LWW INSERT URL], present additional 
representative quotations regarding the personal and organizational factors that facilitated 
participants’ transition to independent funding.
Mid-career challenges and reconceptualizing success
Three themes emerged that brought into question the meaning of success for clinical and 
translational science investigators: (1) lack of confidence and clarity about one’s career; (2) 
broader definitions of success; (3) a broad spectrum of successful career paths.
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Lack of confidence and clarity about one’s career—Although the personal and 
organizational factors outlined above contributed to participants’ career success, a number 
of IF participants who exhibited or had benefited from these factors continued to face 
challenges. Just over half (n = 11; 55.0%) of IF participants expressed either a lack of 
confidence or a lack of clarity about their future career paths.
Louisa (IF) commented in detail on the lack of a “steering wheel” to guide associate 
professors through their mid-career years. This sentiment was echoed by others: “What is 
the end game? Because it’s not necessarily your first R01, but it’s where to take it” 
(Caroline, IF). Participants appreciated the relatively straightforward career path delineated 
during their early-career years when they were guided by their KL2 mentors to secure 
independent funding. However, once that goal was achieved, and particularly after they had 
been promoted to associate professor, they felt there was little guidance on the steps 
necessary to continue to be successful and that such guidance would be helpful:
[Career path planning] seemed so much clearer during the K program, maybe 
because there’s so much more intention and support around it…[It would be 
helpful] to have those processes [about] career plans and…milestones, in the same 
way that you did on the K program. It’s made me question a lot the feasibility of a 
research career and whether it’s really going to work out. (Georgia, IF)
While this lack of career guidance was a challenge to some, a number of participants saw it 
as an opportunity, or at least as a juncture that called for strategic deliberation. Several 
participants stated that they had been intentionally considering their next career steps, trying 
to decide which of multiple paths they would pursue:
[My career direction is] something I’ve been thinking actively about since 
promotion. I know what I am doing now. I know what I want to do over the next 
few years, which is what I’m doing now, just better. But I really don’t know what 
I’m going to be doing in 10 or 15 years. Obviously it’s going to be in [broad field], 
but I don’t know if I want to carve out time to devote to write popular books or if I 
want to keep doing what I’m doing and not really much more, or if I want to take 
on a greater leadership role. (Jack, IF)
Participants who did not articulate a focused plan to continue a particular line of research 
were pondering a variety of potential positions, including in different areas of research, 
clinical care, educational leadership, administration, and health care leadership beyond 
academia. Some perceived a need to change institutions to pursue the opportunities they 
envisaged or to realize their full potential:
Some of my colleagues, people who have been helpful mentors to me in the past, 
have begun to see me as competition in a way, or potentially occupying space that 
they would rather occupy themselves. I like it here. I would like to stay here, but I 
don’t know if to continue to succeed I would have to leave. (Lawrence, IF)
Even IF participants with a clearly delineated career path expressed a lack of confidence in 
their ability to continue securing funding. They agreed that one R01 was insufficient to 
support their research agenda but were unsure whether it was feasible to secure multiple 
grants. They saw their senior colleagues and mentors struggling, and they felt funding 
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decisions could be arbitrary, which led them to question whether they could have successful, 
independently funded research careers long-term:
I’m not sure if I can maintain my career with NIH funding…It’s discouraging when 
I see senior people having these difficulties. How am I going to be able to 
accomplish that when my mentors also have these difficulties? How do I compete 
with them when they are so far along and are themselves discouraged about the 
payline and how difficult it is? So of course I want to continue my research 
program, but it all depends on if I am supported financially to do that. Otherwise I 
am not certain what will happen. (Diana, IF)
Broader definitions of success—Many participants who had less clarity regarding 
their future career path defined success in terms other than the extrinsic grant and 
publication measures often employed by academic medical centers. Instead, they identified 
intrinsic metrics:
Helping all these people is what interests me. Not, “I wrote 70 papers, had two 
R01s and all these foundational grants and this and that.” That to me is a CV, it’s a 
piece of paper, it’s nice, but I don’t know what it gets you at the end of the day. I 
want a more meaningful change. (Robert, IF)
However, these participants acknowledged that working at institutions that used extrinsic 
measures necessitated meeting these goals, even when doing so did not match their own 
professional values or personal definition of success. To varying degrees, participants felt 
this tension and found it frustrating. All participants who described this tension, however, 
understood that these extrinsic measures were what would allow them to continue in 
research; without funding, they would not be able to support their work:
If I don’t meet some of the university’s goals, I can’t achieve my personal goals. I 
wish I could think more that the university’s goals are [mine] and I need to get 
those, but that’s the problem. I can’t. My goals are not materially based. And so I 
find myself constantly knowing that I have to achieve their goals to achieve my 
goals [of conducting my research]. (Louisa, IF)
Many participants judged their success using a variety of intrinsic metrics (see Supplemental 
Digital Table 3 at [LWW INSERT URL]). Belinda (IF) specifically mentioned that, as a 
result of her research, her team is “saving lives,” and so she considered herself successful. 
For others, success meant seeing their research translated into the practice and policy arenas. 
Both IF and NIF participants also offered other measurable extrinsic definitions of success, 
including: being recognized by others for one’s achievements; being given more 
responsibility; being asked to collaborate or to be a mentor; being invited to give talks; being 
asked to participate on national committees; and being awarded prizes, promotions, and 
tenure. Some participants felt that even the extrinsic institutional measures of success, such 
as grants and publications, were intrinsically rewarding after the significant amount of work 
required to write a grant or publish a manuscript.
Some participants’ definition of success rested mainly on their career enjoyment and 
satisfaction. Having fun in their work, seeing themselves as privileged to do what they 
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wanted, interacting with interesting people, and tackling engaging challenges were 
important, particularly for those participants who were either IF or who had pursued a career 
path that did not rely on independent funding. Seeing mentees succeed was also important, 
as it indicated that the participants had left a positive, lasting mark on the scientific 
community and that their mentoring efforts had been fruitful. Greg (IF) suggested that 
trainees’ success and the frequency of being sought out by others for training and 
collaboration were metrics other than grants and publications that institutions could use to 
measure success. Finally, the ability to have a fulfilling professional life and to see, provide, 
and care for one’s family was another definition of a successful career for both IF and NIF 
participants.
A broad spectrum of successful career paths—NIF participants demonstrated that 
career advancement did not rely solely on securing independent funding. Six NIF 
participants had been promoted to associate professor, and ten held other academic or 
national leadership positions, which were either clinical, educational, or within a research 
network, reflective of their respective value to their institutions or of their recognition by 
peers in their fields. These positions suggest that institutions and peers deemed them 
successful by measures other than research funding.
Nathan, Edward, Felix, Xander, and Mark (all NIF) had used their KL2 training to pursue 
career paths that did not rely on independent funding for success. These opportunities led 
them into leadership positions and were made possible only by the knowledge and local or 
national visibility they gained through their KL2 training. Their career paths prioritized 
research to different extents and serve as examples of successful academic medicine careers 
that are open to those who trained in research but that do not depend on independent 
funding.
For example, Nathan (NIF) was hired by another institution to develop its clinical research 
infrastructure and to serve as a mentor to its clinical research trainees. His career goals 
centered on improving patient care from a clinical, as well as research, standpoint. He 
therefore remained interested in conducting research and was glad to continue to be part of 
the research process. His new position came with 50% protected time for research, but the 
institution expected that he would use that time to develop the infrastructure of the clinical 
research program and mentor other investigators. Despite these institutional expectations, he 
continued to align his professional success with securing funding.
Edward (NIF) left a highly supportive environment at his KL2 institution to assume a 
leadership position developing a new hospital-based patient safety and quality program that 
was closely related to his research agenda. While he found the lack of pressure to secure 
funding and the autonomy of the position liberating, he acknowledged the need to secure a 
research grant soon, so that the period without funding on his CV did not harm his future 
research applications. Without the focus on research at his new institution, however, he 
reported struggling to secure adequate resources, such as statistical support.
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Felix (NIF) was recruited to another institution to establish and lead a new clinical section. 
He saw his likely future involvement in research as mentoring junior investigators in his 
section or as a co-investigator on others’ grants.
Xander (NIF) similarly prioritized mentorship and collaboration, in addition to securing 
grants as a PI. He entered his field when it was relatively new and lacked a distinct direction 
for a number of years, until he became involved with a national research network. He 
considered himself a steward for the field, guiding junior faculty to develop more structured 
career paths than had been available for him. He focused his research efforts on playing a 
collaborative and mentoring role, particularly as part of the national research network to 
which he belonged.
Mark (NIF) had originally intended to be a clinical investigator, pursuing an outcomes-based 
project focused on a disease area. However, he found himself gravitating toward teaching 
others how to navigate the world of clinical research and complete their own research. He 
chose a position that had a formal mandate to educate students and residents, so he received 
salary support to do so. His main enjoyment in conducting research came from working with 
others, and he was able to do so as a mentor and collaborator, more so than if he were 
leading his own research projects. Ultimately, he saw himself equally as a clinician, an 
investigator, and an educator, devoting time to each role.
Discussion
This study, designed around the Rubio model of physician-scientist career success,16 
revealed the personal and organizational factors that facilitate the transition to an 
independent clinical and translational research career. These factors include networks, 
persistence and resilience, initiative, autonomy, personal and professional balance, 
appropriate mentorship, protected time for research, and institutional resources and support.
Many of these factors are related, which may explain why the absence of any one can derail 
an individual’s career. Junior faculty with an appropriate level of autonomy are more likely 
to carve out a career that is engaging and fulfilling for them, and to find an acceptable 
balance between their personal and professional obligations. Thus, they pursue a line of 
work for which they are highly motivated. Being motivated to engage in this type of work 
may drive an individual’s initiative and fuel her or his persistence and resilience. Those who 
enjoy their work and/or are strongly motivated to find answers to specific research questions 
or to improve public health—all definitions of success used by participants in our study—
may be more likely to act to enhance their likelihood of career success, persist in 
challenging circumstances, and be resilient to multiple setbacks. Faculty with strong 
initiative may be more likely to seek out and establish mentoring and collegial relationships 
with colleagues who can help them in their careers. They also are more likely to have 
extensive networks and to benefit from the many ways in which mentors can assist them. 
Having extensive networks and helpful mentors, in turn, can provide social support and role 
modeling for junior faculty, which may further enhance their resilience and foster 
perseverance. With these personal factors in place, participants were better positioned to 
succeed, as long as they also had access to the appropriate institutional resources. A long-
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established theory of career motivation posits that resilience, autonomy, and initiative 
(“situations in which outcomes are contingent on their behavior”) tend to go together with 
career motivation,20 supporting our findings of the interrelatedness of these factors.
While this interrelatedness is appealing if one has, or can develop, each factor, it is 
problematic for those who, for whatever reason, find themselves lacking in one particular 
area. Without a strong drive to establish oneself as a PI, junior faculty may struggle to 
arrange sufficient autonomy over their work, instead working to support others’ research. 
They then are more dependent on their mentors as supervisors. If their mentors are not 
supportive, the individual may find it difficult to become independent.
Of all the organizational factors, mentoring emerged as the most important. Unsupportive 
mentors—whether due to lack of time, availability, interest, or desire to help—affected some 
NIF participants’ lack of funding. Mentors who did not have the appropriate content 
knowledge or networks either did not engage in the mentoring relationship or behaved in a 
bullying manner. Either way, they were detrimental to their mentees’ careers. Conversely, 
many IF participants credited their success to their mentors.
Mentoring in academic medicine has been studied extensively. A 2006 systematic review 
found that mentors played an important role in academic medical careers, including 
providing career guidance, which encompasses the advice and role-modeling found in this 
study, and fostering research productivity.21 Mentors also helped junior investigators by 
providing resources, and investigators with research mentors had more time for research,21 
in line with our finding that protected time for research was crucial for securing independent 
funding. A 2010 systematic review found that mentors should be well-established in their 
academic community,22 which further affirms our finding of the benefit of having access to 
a mentor’s network. This finding is partly in contrast to the opinions of KL2 program 
directors, who did not value as highly as our participants both the initiative junior faculty 
showed in seeking the advice of colleagues and the importance of having research interests 
that meshed with institutional strengths.23
Other findings from our study regarding mentorship reflect those findings reported in the 
literature. For example, one study reported that mentoring was the first or second most 
influential factor hindering career progress in academic medicine,24 while another found that 
mentoring significantly reduced the time to promotion in academic medicine.25 Role 
modeling by mentors has only recently been fully acknowledged in the literature as 
improving career outcomes.26 Finally, DeCastro and colleagues27 determined that it was 
highly improbable for one individual to fulfill all the needs of a junior investigator, 
supporting the need for multiple mentors.
NIH has recognized the importance of protected time in research careers, requiring and 
providing 75% (50% for surgeons) protected time for research and training for career 
development awardees. All participants in our study had at least two years of this support 
through a KL2 award; some had received as many as five years of support. Some NIF 
participants reported that their time was not properly protected during their KL2 award. 
Their inability to focus on their research had a negative effect on their productivity and 
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transition to independent funding. Other NIF participants reported that only two years of 
support was insufficient to establish their research agenda and that they would have 
benefitted from at least another year of funding. Some IF participants, conversely, described 
their tactic of focusing only on their research topic, even in their clinical, administrative, 
educational, and service work. They organized their unprotected time to support and 
advance their research agendas. Research has shown that protected time is critical to faculty 
job satisfaction28 and physicians’ publication rates.29 These findings also suggest the need 
for alternative mechanisms to protect early-career investigators from the demands of clinical 
responsibilities during a critical period of their research career development.
Our findings underscore the benefit cross-disciplinary research resources can have on early-
career faculty, suggesting that resources should continue to be allocated in this way. NIF 
participants who moved from resource-rich institutions to those with less infrastructure 
experienced difficulty re-establishing their research and finding the support or facilities to 
perform their work and transition to independent funding. The NIH’s recognition of the 
importance of such resources to streamline the process and enhance the timeline for 
translational discovery was a fundamental tenet underlying the creation of the CTSA 
program.30
Our findings provide insight into our emerging understanding of what is meant by success 
for clinical and translational investigators, particularly KL2 awardees. We uncovered the 
ways by which participants judged their own success, beyond grants and publications. These 
definitions of success were both intrinsically motivated, such as improving health and health 
care, enjoying one’s work, and seeing trainees succeed, and extrinsically motivated, such as 
receiving external validation and recognition for one’s accomplishments and providing for 
one’s family. Our study also characterized the elements of successful career paths that 
extended beyond being an R01-funded PI. Some participants held leadership positions that 
did not rely on independent funding; these individuals were recognized by their institutions 
as being successful because they had been appointed to these positions.
The cases of the NIF participants who were successful in other domains suggest that faculty 
leaders need to reconsider the goals and success metrics for career development awardees. 
Felix, Mark, and Xander all saw their future roles in research as collaborators rather than 
PIs. Other NIF participants also had substantial co-investigator support from others’ grants 
while they pursued their own independent funding. An emerging area of importance in the 
CTSA community is understanding and developing team science to augment and accelerate 
scientific discoveries and their translation to human health care.31 Our findings support this 
increasing interest in team science and the wider array of faculty career paths it provides. 
Given the challenging funding climate and the increasing appreciation for the role of team 
science in the generation of new knowledge,13 questioning whether investigators must 
obtain independent funding to be considered successful is becoming more relevant. Instead, 
faculty may have a demonstrable role (including funded effort) on a team-based project, thus 
remaining in research without being a PI, as was the case for some NIF participants. Some 
institutions, such as the University of North Carolina at Chapel Hill School of Medicine,32 
now recognize key team science roles and accomplishments as elements that support 
successful promotion and tenure applications. As research teams expand and the range of 
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disciplines collaborating on innovative projects increases, more investigators will participate 
on a team without having a leadership position. Expanding the available career paths may 
allow K awardees to make the best use of their training opportunities and protected time. In 
turn, they may be more productive and successful, whatever their chosen path, as they come 
off their career development award and transition to mid-career.
Participants also identified the challenges perceived by mid-career clinical and translational 
investigators who had transitioned to independent funding (i.e., are considered 
“successful”), which include the absence of: (1) established benchmarks and milestones as 
guideposts for developing one’s long-term research goals, (2) sustained guidance beyond the 
attainment of one’s first independently-funded grant, and (3) a supportive institutional 
culture to bolster one’s confidence to continue to compete successfully for grant funding. 
These challenges have received relatively little attention in the literature, but previous 
studies have arrived at similar findings to ours. Mid-career faculty frequently experience a 
transitional period during which their professional focus changes.33 In one study, faculty in 
a variety of non-professional (i.e., excluding academic medicine, amongst others) disciplines 
reported having unclear goals, being uncertain about where to develop their niche, and 
feeling concerned about how to remain competitive, in addition to other challenges.34 An 
opinion piece providing advice to mid-career faculty in academic medicine included 
substantive discussion of maintaining funding and mentioned “rejuvenation,” which may be 
akin to our finding regarding expanding one’s area of focus.35 A study of mid-career women 
faculty in academic medicine found that establishing work-life balance and making 
important contributions to their field were central components of participants’ definitions of 
success,36 further validating our findings.
Mid-career faculty may start to move away from the close mentoring relationships they 
enjoyed as junior faculty, becoming more equal colleagues and collaborators with their 
former mentors. Although advice from mentors remains important for faculty at all levels, 
the close monitoring of progress and regular meetings that are built into KL2 programs 
likely have disappeared by mid-career, as some participants who were further along in their 
careers reported. Mid-career faculty are more likely mentoring others. However, at this point 
in their careers, clinical and translational investigators likely could specifically benefit from 
career mentoring as they strategize about their long-term goals.33
Implications
Our findings have implications for many groups, including career development awardees, 
mentors, division/department chairs who support junior faculty, and institutional leaders.
Personal factors—Investigators should develop and routinely practice the personal 
factors participants described. They should:
• Cultivate and use networking skills,
• Seek help to reframe negative experiences and rejections in ways that develop 
resilience and encourage perseverance,
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• Be respectfully assertive in taking the initiative to develop their career and to 
secure the resources they need,
• Take ownership of their work to achieve a sense of autonomy,
• Arrive at an understanding of their personal and professional balance and 
continuously strive to maintain it,
• Assemble a team of available and dedicated mentors with significant career 
experience, wide networks, and appealing career paths, and ask those mentors to 
role model the behaviors that facilitate career success,
• Be persistent and vocal advocates for protected time and seek the support of 
mentors and institutional leaders in working toward that goal,
• Identify institutions with welcoming investigators in their discipline; relevant 
patient populations; comprehensive, pertinent, and available research facilities; and 
logistical support, and
• Seek help in learning to delegate and find people to whom to delegate.
Organizational factors—Many of the practical steps that institutions can take to facilitate 
junior faculty members’ careers involve providing financial resources. We recognize that in 
the current resource-tight environment, the provision of additional resources may be 
challenging for institutions. However, resources spent on junior faculty may pay dividends 
as their careers develop. Institutions should:
• Require all associate and full professors to participate in effective mentor training 
and provide financial support for mentors,
• Offer assistance in arranging mentoring teams for junior faculty,
• Support broad interpretations of career success (beyond grants and publications),
• Appoint leaders who understand research careers and are sympathetic to their 
inherent challenges, and assess this trait in annual performance evaluations,
• Regularly ask junior faculty what they need to be successful and respond where 
possible,
• Protect faculty time,
• Offer courses and mentorship in how to delegate tasks and provide skilled 
administrative and support staff,
• Intentionally develop communities of investigators in specific fields and coordinate 
clinical recruitment to ensure investigators have access to multiple patients in the 
same fields,
• Promote a culture of collaboration—one that facilitates collaborative research,
• Include in tenure and promotion guidelines information about collaborative career 
paths and how to assess team scientists,
• Provide administrative and logistical support to establish team projects, and
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• Give institutional leaders a mandate to propose collaborations and make 
introductions across the institution.
In addition, our findings suggest the need for discussion at the federal level regarding the 
indirect costs covered by NIH mid-career mentorship awards (i.e., K24). The substantial 
difference in what is covered by a K24 award and what is covered by an R01 award has 
meant that institutional leaders traditionally have valued mentoring awards less than 
research awards; therefore, faculty feel pressured to focus on their research rather than on 
mentoring others.
Limitations and future research
Our study depended on KL2 alumni volunteers and is therefore not representative of all 
investigators. Limiting our study to institutional career development awardees excluded the 
many investigators without these helpful awards. Thus, future studies could explore the 
factors that facilitated or hindered the progress of mid-career faculty who succeeded and 
persisted without the aid of a career development award.
Another notable limitation is the exclusion of individuals who left academia. These 
individuals may perceive themselves as having “failed” their program, and may be reticent 
to discuss this, even with the guarantee of anonymity. Future studies could solicit the 
opinions of KL2 alumni who left academic positions to determine what organizational or 
personal factors helped or hindered their careers and how they define career success. Such a 
qualitative study would complement quantitative studies conducted with a broader 
population of academic medicine faculty.37 Similarly, these individuals could help identify 
the skillsets they acquired from mentored training that are most helpful in their chosen 
career paths.
Our study had an equal number of male and female participants in both funding groups, and 
we found no notable differences between the sexes. However, relatively few participants 
were racial or ethnic minorities. Since the career pipeline in academic medicine is 
particularly “leaky” for women and those from diverse backgrounds,1–3 future studies 
should focus on the personal factors that facilitate the transition to independent funding for 
those from diverse and underrepresented backgrounds.
Additional studies could investigate how particular facets of career success are built. For 
example, what steps should programs take to instill persistence and resilience in their 
trainees? What networking skills could help scholars be more proactive in building a 
research network? How do programs help mentors allocate appropriate levels of autonomy 
for each mentee? How do some institutions find resources to support early-career faculty? 
Future organizational studies could examine the fiscal feasibility of pursuing a career path 
when one is primarily a collaborator, rather than a PI, so that those who want to pursue this 
pathway have some guidance on how to support themselves without their efforts being 
diluted by too many diverse demands. Finally, further work is needed to understand how 
best to measure the success of training and career development program alumni, if not by 
publications and grants, so that programs can be effectively evaluated while still 
acknowledging a broad spectrum of successful career paths.
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Conclusions
In this study, we examined the personal and organizational factors that facilitate junior 
investigators’ transition to independent funding. We also extended our understanding of 
what it means to be successful in a clinical and translational research career. The factors we 
identified aligned with the building blocks in the Rubio model of physician-scientist career 
success.16 The psychosocial milieu and personality elements of the Rubio model are 
relevant to KL2 awardees trying to secure independent funding. In addition, the 
organizational factors in the Rubio model align with those that emerged in our study. Our 
findings regarding protected time are reflected in the organizational factors of the Rubio 
model, like “conflicting demands.” The relational factors in the Rubio model include both 
mentoring and networking, the latter of which emerged as both a personal and 
organizational factor in our study—we found that individuals should focus on acquiring 
networking skills and being proactive in forming a network and that institutions should 
provide a collaborative culture and community of investigators. Awareness of these factors 
can help junior investigators be intentional about seeking the support, resources, and skills 
they need for a successful clinical and translational science career.
We also explored what it means to be successful. Our findings again support the Rubio 
model, with its extrinsic and intrinsic outcome components, but they also suggest the need to 
expand our definition of success for this population. The non-traditional career paths 
demonstrated by some participants showed how some components of extrinsic success, such 
as having a leadership position and being promoted, can be pursued in place of other 
components, like securing grants. Our findings also demonstrate the transient and relative 
nature of success; a faculty member who has secured independent funding may question her 
or his career goals a few years later. Understanding the nuances underlying various types of 
career success can help determine appropriate career paths, business models, and strategies 
for achieving goals that align with investigators’ individual interests and skill sets in today’s 
environment of funding challenges and the increasing importance of team science.
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Table 1
Characteristics of the Nine Clinical and Translational Science Award-Funded Institutions Participating in a 
Study of the Factors that Facilitate Junior Investigators’ Transition to Independent Funding, 2013–2014
Institution Region Governance No. (% of 40) participants
Cleveland Clinic/Case Western Reserve Midwest Private 4 (10)
Columbia University Northeast Private 3 (8)
Johns Hopkins University Southeast Private 5 (13)
University of California, San Francisco West Public 4 (10)
University of Pittsburgh Northeast State-related 8 (20)
University of Texas Southwestern Medical Center Southwest Public 5 (13)
Vanderbilt University Southeast Private 3 (8)
Washington University in St. Louis Midwest Private 3 (8)
Yale University Northeast Private 5 (13)
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Table 2
Demographic Characteristics of the 40 Participants in a Study of the Factors that Facilitate Junior 
Investigators’ Transition to Independent Funding, by Funding Status, 2013–2014
Characteristic No. independently funded No. not independently funded
Race
 White 16 12
 Asian 3 4
 African American 0 1
 Does not wish to identify 1 3
Ethnicity
 Not Hispanic/Latino 17 16
 Hispanic/Latino 2 2
 Does not wish to identify 1 2
Academic rank
 Assistant professor 10 14
 Associate professor 10 6
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